GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Inventory-to-Revenue

Zahravi Pharmacutical Co (XTEH:DZAH1) Inventory-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Zahravi Pharmacutical Co's Average Total Inventories for the quarter that ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Revenue for the six months ended in . 20 was IRR0.00 Mil.

Zahravi Pharmacutical Co's Inventory-to-Revenue for the quarter that ended in . 20 stayed the same from . 20 (0.00) to . 20 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.


Zahravi Pharmacutical Co Inventory-to-Revenue Historical Data

The historical data trend for Zahravi Pharmacutical Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Inventory-to-Revenue Chart

Zahravi Pharmacutical Co Annual Data
Trend
Inventory-to-Revenue

Zahravi Pharmacutical Co Semi-Annual Data
Inventory-to-Revenue

Competitive Comparison of Zahravi Pharmacutical Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Zahravi Pharmacutical Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zahravi Pharmacutical Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zahravi Pharmacutical Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zahravi Pharmacutical Co's Inventory-to-Revenue falls into.



Zahravi Pharmacutical Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Zahravi Pharmacutical Co's Inventory-to-Revenue for the fiscal year that ended in . 20 is calculated as

Inventory-to-Revenue (A: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Revenue (A: . 20 )
=( ( + ) / 1 ) /
=0 /
=N/A

Zahravi Pharmacutical Co's Inventory-to-Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue (Q: . 20 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Revenue (Q: . 20 )
=( ( + ) / 1 ) /
=0 /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co  (XTEH:DZAH1) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Zahravi Pharmacutical Co's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory=Average Total Inventories (Q: . 20 )/Cost of Goods Sold (Q: . 20 )*Days in Period
=0/*365 / 2
=

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Zahravi Pharmacutical Co's Inventory Turnover for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines